Introduction
NGF is the best characterized member of the neurotrophin family, which includes brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4/5 (NT-4/5) (Levi Montalcini, 1987; Snider, 1994) . The biological response of neurotrophins is mediated by two types of structurally unrelated neurotrophin receptors: p75, also known as gp75 NGFR or LNGFR, and speci®c transmembrane tyrosine kinase receptors (trk). While all neurotrophins bind to p75 with low anity, they show high anity binding with a preferred member of the trk family. Promiscuity of ligand-receptor interactions has been shown to occur, although NGF predominantly binds to trkA, while BDNF and NT-4/5 preferentially interact with trkB. NT-3 is the only known ligand that can eectively activate trkC (Chao, 1994; Meakin and Shooter, 1992; Barbacid, 1993 Barbacid, , 1995 van der Geer et al., 1994; Kaplan and Stephens, 1994) .
The trkA receptor undergoes dimerization, followed by autophosphorylation regulated by the intrinsic receptor tyrosine kinase activity upon interaction with NGF Jing et al., 1992; Cordon Cardo et al., 1991) . The phosphorylated tyrosine residues of the receptor then act as docking sites for other signaling molecules, such as Shc, GRB2, crk, PLC, etc., through specialized protein domains (i.e. SH 2 and SH 3 domains) (Kim et al., 1991; Vetter et al., 1991; Ohmichi et al., 1994; Basu et al., 1994; Torres and Bogenmann, 1996) . This multimeric receptor complex is thought to mediate the signal via the ras, raf, MEK pathway to the nucleus, where activation of immediate early response genes (i.e., c-fos, Egr-1) occurs (van der Geer et al., 1994; Gomez and Cohen, 1991; Howe et al., 1992; Thomas et al., 1992; Curran et al., 1982) .
The signal pathway and the biological consequences of p75 receptor activation by NGF is much less well de®ned. The p75 gene, when transfected into nonneuronal cells, was shown to generate low anity NGF binding sites, while expression in neuronal cells induced NGF-mediated cell dierentiation (Hempstead et al., 1989; Johnson et al., 1986; Matsushima and Bogenmann, 1990; Pleasure et al., 1990) . Complex formation between p75 and trkA was observed, thus enhancing the NGF signal (Hempstead et al., 1991; Verdi et al., 1994) . However, the p75 receptor belongs to the family of tumor necrosis factor receptors, and over expression in brain-derived cell lines induced apoptosis in the absence of NGF (Chao, 1992; Rabizadeh et al., 1993) . The p75 receptor also was shown to mediate NGFinduced activation of the sphingomyelin cycle, as well as activation of the NF-kB pathway, strongly suggesting that p75 is a neurotrophin receptor (Carter et al., 1996; Dobrowsky et al., 1994) .
Regulation of neurotrophin receptor genes by dierent agents has been studied in various cell types. NGF up-regulates the level of p75 mRNA in PC12 cells, sensory neurons, and sympathetic ganglion cells, while RA and basic ®broblast growth factor (bFGF) increased the number of low-anity NGF-binding sites in dierent cell lines (Birren and Anderson, 1990; Scheibe and Wagner, 1992) . Transcriptional control of the trk gene expression seems to be even more complex, since NGF increased trkB gene expression in glial cells, while inducing the level of trkA mRNA in PC12 cells (Holtzman et al., 1992; Wyatt and Davies, 1995; Kumar et al., 1993) . NT-3 induced trkA gene expression in primary neuroblasts, while membrane depolarization and levels of intracellular cAMP also stimulates expression of the receptor (Birren et al., 1992; Verdi and Anderson, 1994) . Recently, RA and interferon gamma (INF-g) also were shown to upregulate trkA gene expression, albeit by a posttranscriptional mechanism and increased expression did not elicit an NGF-mediated biological response (Lucarelli et al., 1995) .
Neuroblastoma (NB), a common solid tumor in childhood, is thought to be derived from sympathoadrenal progenitor cells. The biological behavior of these tumors varies, with some of the tumors regressing spontaneously, while others grow progressively and metastasize, even during aggressive treatment (Seeger and Reynolds, 1993; Seeger et al., 1982) . Recently, we demonstrated that trkA gene expression directly correlates with favorable outcome, thus implicating the NGF/trkA pathway in NB tumorigenesis (Nakagawara et al., 1992 (Nakagawara et al., , 1993 Suzuki et al., 1993) . This was further substantiated by stable transfection of the trkA receptor gene into an NGF non-responsive NB cell line (HTLA230) that became terminally dierentiated upon activation of the NGF/trkA signal pathway by NGF (Matsushima and Bogenmann, 1993) . Hence, loss of a functional NGF/trkA signal pathway contributes to NB oncogenesis.
To investigate the regulation of NGF responsiveness in human NB and to study the potential role of the NGF/trkA signal pathway in this tumor, we used two independently isolated cell lines (GOTO, HTLA230) (Matsushima and Bogenmann, 1992a; Sekiguchi et al., 1979 ). Here we demonstrate that RA transcriptionally activates trkA gene expression in GOTO cells, but induces trkB gene transcription in HTLA230 cells, while CNTF induced trkA gene transcription in both cell lines. Elevated trkA receptor levels elicit a transient growth response in GOTO cells upon NGF stimulation, while HTLA230 cells become dierentiated in the presence of CNTF and NGF.
Results and discussion
GOTO and HTLA230 cells were isolated independently from patients with advanced-stage NB. Both cell lines share the hallmarks of advanced NB tumors, including N-myc gene ampli®cation, aneuploid set of chromosomes, a highly cellular histopathology, and growth in vitro and in athymic nude mice (Matsushima and Bogenmann, 1992a; Sekiguchi et al., 1979) . Given the importance of neurotrophins and their receptors in NB oncogenesis we investigated the regulation of NGF responsiveness in these two cell lines, since both share similar biological characteristics, yet dier in neurotrophin receptor gene expression. GOTO cells express low levels of both the p75 and the trkA gene, while HTLA230 cells were shown to express neither the p75 nor any of the trk genes (Matsushima and Bogenmann, Figure 1 (a) GOTO cells were grown in medium for 2 days followed by stimulation with either NGF (50 ng/ml), RA (5610 76 M), BDNF (50 ng/ml), NT3 (50 ng/ml), NT4/5 (50 ng/ml), for 45 min prior to harvest. Total RNA (25 mg/lane) was hybridized with the Egr-1 probe. NGF treatment induced Egr-1 gene transcription, suggesting the presence of trkA receptors. Neither BDNF, NT3 nor NT4/5 induced an immediate early response, consistent with the lack of functional trkB and trkC receptors. (b) GOTO cells were grown in medium alone or medium supplemented with RA followed by stimulation with decreasing concentrations of NGF for 45 min prior to harvest. Total RNA was hybridized with the Egr-1 probe. GOTO cells pretreated with RA showed an increased sensitivity to NGF when compared to RA untreated cells, and Egr-1 gene activation occurred by physiological NGF concentrations. (c) GOTO cells were grown in medium alone or medium supplemented with RA and total RNA was isolated at indicated time points to determine the time course of trkA and p75 gene activation by RA. A steady increase in the level of trkA mRNA occurred within 4 h of RA treatment and the abundance of trkA message remained elevated thereafter. In contrast, levels of p75 mRNA also increased within a similar time frame, but declined to assume base level expression 24 h later. The tubulin message pool remained unchanged. (d) GOTO cells grown for 2 days in medium alone followed by incubation with actinomycin D (ActD) (5 mg/ml) for 6 h in the presence or absence of RA. Total RNA was isolated and hybridized with probes for trkA, p75 and tubulin genes. Cells grown in the presence of medium alone and ActD showed a reduced level of trkA and p75 mRNA while stimulation with RA exhibited the expected increase in message pool for both genes. However, the RA mediated increase in trkA and p75 message levels was abolished in the presence of ActD, consistent with a model of transcriptional activation of these neurotrophin receptor genes by RA 1992a, 1993). Thus, the response of GOTO cells to dierent neurotrophins was investigated to determine the presence of functional trk receptors (Figure 1a) . Activation of Egr-1 (Milbrandt, 1987) , an immediate early response gene was used as an indicator. GOTO cells were grown at equal cell density for 2 days, incubated in serum-free medium for 1 h, followed by a 45-min treatment with either solvent alone, NGF (50 ng/ml), RA (5610 76 M), BDNF (50 ng/ml), NT3 (50 ng/ml), or NT 4/5 (50 ng/ml). Northern blot analysis demonstrated that activation of the Egr-1 gene occurred upon stimulation with NGF, indicative of functional trkA receptors. Lack of Egr-1 gene activation upon BDNF, NT3, or NT4/5 incubation suggested the absence of trkB and trkC receptors, which was substantiated by Northern analysis using receptor gene speci®c probes (data not shown).
Retinoic acid (RA) can induce morphological and molecular changes in human NB, including responsiveness to neurotrophins (Thiele et al., 1985; Matsushima and Bogenmann, 1992a; Lucarelli et al., 1995) . Hence, GOTO cells were grown in the absence or presence of RA for 2 days, followed by incubation with decreasing concentrations of NGF for 45 min to determine trkA mediated Egr-1 gene activation ( Figure 1b ). Data from these experiments suggested that RA pretreatment enhanced the sensitivity of GOTO cells to NGF, since physiological concentrations of NGF were capable of inducing a biological response, when compared to RA untreated cells. The time course and the mechanism by which RA enhances NGF sensitivity was subsequently investigated (Figure 1c) . A rapid increase in the steady state level of trkA mRNA occurred within 4 h following RA treatment, and elevated mRNA levels were present thereafter. The morphogen also induced a rapid, but transient, increase in the level of p75 mRNA which, in contrast to trkA, dropped to a pretreatment steady state level 24 h later. While a constant high level of trkA gene expression may facilitate a growth and/or dierentiation signal by NGF, the functional significance of a transient induction of p75 gene expression by RA is more dicult to explain. However, similar kinetics of transient transcriptional activation of a transfected p75 promoter-CAT construct has been observed upon stimulation of the cells with bFGF, suggesting that p75 may have characteristics of an immediate early response gene (Taiji et al., 1992) .
The molecular mechanism by which RA induced trkA gene expression in GOTO cells was investigated next, since a post-transcriptional mechanism of trkA gene regulation by RA has been suggested (Lucarelli et al., 1995) . GOTO cells were grown for 2 days in medium followed by incubation for 6 h with either medium alone, medium supplemented with actinomycin D (ActD) (5 mg/ml), RA or RA plus ActD. Total cellular RNA was isolated and hybridized with probes for trkA, p75 and tubulin genes ( Figure 1d) . Data from this analysis demonstrated that treatment of cells with ActD prevented the RA induced increase in steady state level of trkA and p75 mRNA, while no signi®cant changes in tubulin gene expression occurred. The RA mediated increase in trkA and p75 mRNA is independent of de novo protein synthesis, as this increase in the steady state level of the mRNA's also occurred in the presence of anisomycin, a potent inhibitor of protein synthesis (data not shown). Taken together, these observations are consistent with the model, that the observed RA mediated increase in trkA and p75 gene expression in GOTO cells is due to transcriptional activation of the genes, rather than stabilization of the message, as previously suggested (Lucarelli et al., 1995) .
The RA-mediated increase in total cellular trkA protein was analysed using immunoprecipitation and immunoblots ( Figure 2 ). GOTO cells were grown in the presence or absence of RA for various time periods. Prior to harvesting the cells, cultures were incubated for 1 h in serum-free medium, after which cells were treated for 5 min with NGF to study receptor activation. Immunoblot analysis of total cellular lysates using an anti-trk antibody showed a (Figure 2a , bottom panel) was observed using an anti-phosphoty-rosine (PY) antibody, while pretreatment with RA signi®cantly increased NGF-induced tyrosine phosphorylation of several prominent proteins with an apparent molecular weight of 140 kDa, 110 kDa, 65 ± 70 kDa, 60 kDa, and 40 ± 42 kDa, respectively. The 140 kDa band, which co-migrated with the protein band identi®ed by the anti-trk antibody, showed a strong increase in tyrosine phosphorylation consistent with trkA activation by NGF. Immunoprecipitation of the trkA receptor form these lysates, followed by immunoblotting with the anti-trk antibody, con®rmed the presence of low levels of trkA protein in control cells, while RA treatment signi®cantly increased the total trkA protein ( Figure  2b ). Subsequent immunoblotting with a PY antibody revealed low levels of phosphorylated trkA protein in RA-untreated cells upon NGF stimulation, while a substantial increase in activated trkA protein occurred in cells grown in the presence of RA. An increase in surface bound receptor expression could also be con®rmed by Fluorescence Activated Cell Sorter (FACS) analysis using an anti-human trkA antibody, demonstrating an increase in¯uorescence intensity of RA treated cells when compared to untreated control cells (data not shown). Hence, an RA-mediated increase in trkA mRNA is rapidly followed by an increase in total and surface bound trkA receptors which are susceptible to ligand stimulation.
Previously we showed that RA does not induce trkA gene expression in HTLA230 cells; however, transcription activation of the trkB gene by the morphogen has been observed with some cell lines in vitro (Lucarelli et al., 1995; Kaplan et al., 1993) . Thus, we investigated the potential of RA to induce expression of other trk genes. GOTO and HTLA230 cells were grown in either medium alone or medium supplemented with RA for 3 days followed by stimulation with either NGF or BDNF. Total cell lysates were immunoprecipitated using an anti-trk antibody and analysed as above (Figure 3 ). GOTO cells grown in medium alone or in the presence of RA expressed a trk protein that was tyrosine phosphorylated upon NGF, but not BDNF stimulation, consistent with the presence of trkA, but not trkB receptors. In contrast, HTLA230 cells when grown in the presence of RA expressed a trk receptor which was phosphorylated upon BDNF, but not NGF stimulation indicating the expression of trkB, but not trkA receptors. In neither cell line did we ®nd expression of trkC receptors before or after RA treatment. Hence, RA selectively induced trkA gene expression in GOTO cells, while activating trkB gene expression in HTLA230 cells.
Lack of trkA gene activation by RA in HTLA230 cells may be the consequence of a mutated trkA gene or the inability of the cells to transmit an RA signal, although these cells show morphological and molecular neuronal dierentiation in the presence of the morphogen (Matsushima and Bogenmann, 1992a) . Rat sympathoadrenal progenitor cells have been demonstrated to become NGF responsive in the presence of ciliary neurotrophic factor (CNTF) . CNTF binds to a tripartite receptor complex, which mediates its signal via the JAK/STAT pathway and thus diers from the nuclear receptor pathway of RA (Davis and Yancopoulos, 1993; Stahl and Yancopoulos, 1994) . Since NB is a tumor of the sympathoadrenal lineage, we investigated whether CNTF induces NGF responsiveness in HTLA230 cells (Figure 4 ). Cells were grown for 3 days in medium alone or in medium supplemented with either CNTF (50 ng/ml), NGF, leukemia inhibitory factor (LIF) (1000 U/ml), a cytokine that shares the b subunit of the CNTF receptor (Davis et al, 1994) and thus has a similar signal pathway as CNTF, or interferon-g, (IFNg) , previously demonstrated to activate trk genes (Lucarelli et al., 1995) . Cells were stimulated with NGF for 5 min prior to harvest. Equal amounts of total protein were then immunoprecipitated with the anti-trk antibody and analysed as above. CNTF and LIF, but not INF-g, substantially increased the level of total trkA protein that was tyrosine phosphorylated upon NGF stimulation (Figure 2a) . Induction of trkA gene expression occurred during the ®rst 24 h of treatment, after which a gradual increase in total trkA protein was seen (Figure 2b ) and 20 ng/ml of CNTF was sucient for maximal stimulation (Figure 2c) .
The mechanism by which CNTF induced trkA expression was investigated using a similar approach as described above. HTLA230 cells were grown in medium without or with CNTF (20 ng/ml) for 3 days followed by incubation with or without ActD (5 mg/ ml), for 6 h. Prior to harvest, cells were also treated with NGF for 40 min to determine the onset of c-fos gene induction as an indicator of functional high anity NGF receptors. Total cellular RNA was isolated and analysed by Northern blots (Figure 5 ).
Figure 3 GOTO and HTLA230 cells were grown in medium alone or medium supplemented with RA for 2 days followed by stimulation with either NGF or BDNF prior to harvesting total cell proteins. Cell lysates were then immunoprecipitated with a pan-trk antibody and analysed as above. Incubation of GOTO cells with NGF showed a phosphorylated trk band and pretreatment of cells with RA increased the total amount of phosphorylated trk protein, consistent with the presence of trkA. However, GOTO cells grown in the absence or presence of RA were not susceptible to BDNF stimulation, since no tyrosine phosphorylated trk protein was present, suggesting a lack of trkB receptors. In contrast, neither NGF nor BDNF activated trk receptors in control HTLA230 cells, while RA pretreatment enabled cells to functionally respond to BDNF, but not NGF, consistent with the presence of trkB, but not trkA receptors Data from these experiments demonstrated that CNTF activated trkA gene expression by a transcriptional mechanism, since ActD prevented the increase in the level of trkA mRNA (Figure 5a) . Hybridization of the Northern blot with a c-fos probe demonstrated that NGF stimulation activated the c-fosgene in CNTF treated HTLA230, con®rming the expression of the trkA gene. The c-fos gene activation was abrogated in cells pretreated with ActD. Similarly, ActD prevented the CNTF mediated increase in total trkA protein in HTLA230 (Figure 5b ) as determined by immunoprecipitation experiments. These data demonstrated a transcriptional rather than post-transcriptional regulatory mechanism of trkA gene expression by CNTF. We further concluded that HTLA230 cells harbor a silent trkA gene which can be transcriptionally activated by cytokines such as CNTF and LIF, known inducers of neuronal dierentiation . Similar data were obtained with GOTO cells upon CNTF treatment, suggesting that this dierentiation pathway may be intact in many NB cells.
A hallmark of many membrane bound receptors is their immediate down regulation upon ligand binding (Sorkin and Waters, 1993) . We noticed that GOTO and HTLA230 cells rapidly lose surface bound trkA receptors in the presence of NGF as demonstrated by FACS analysis, despite the presence of high levels of trkA mRNA (data not shown). De novo trk biosynthesis ( Figure 6a ) and receptor degradation ( Figure 6b ) were subsequently analysed in order to determine the mechanism of receptor down regulation. GOTO cells, grown for 24 h in RA, were maintained for 1 h in methionine-free medium, followed by incubation with or without NGF. Cells were labeled for 15 min Figure 4 HTLA230 were grown in the presence of the indicated agents (CNTF, 50 ng/ml, NGF, 50 ng/ml, LIF, 1000 U/ml, IFNg, 250 U/ml) for 3 days and stimulated for 5 min with NGF prior to harvesting total cell proteins which were immunoprecipitated with an anti-trk antibody and analysed as described. However, autoradiographic analysis demonstrated that equal amounts of radioactivity were incorporated into newly synthesized trkA protein in the absence or presence of NGF, suggesting that de novo synthesis of trkA protein was unaected by the ligand of trkA. TrkA receptor degradation in the presence or absence of NGF was investigated using a pulse/chase analysis. Cells were grown in RA for 24 h and labeled for 30 min with 35 S-marked amino acids. The label was then washed out, and cells were incubated both with and without NGF for the indicated time intervals, after which cell lysates were prepared and analysed as described above. A continuous decrease in total trkA protein occurred upon NGF stimulation, as determined by immunoblotting with the pan-trk antibody, resulting in a nearly complete loss of immunodetectable trkA within 4 h. However, newly synthesized, radioactively labeled trkA protein migrated with an apparent molecular weight of approximately 110 kDa and matured thereafter by post-translational modi®cation to its known molecular weight of 140 kDa. Maturation of the de novo synthesized trkA protein occurred equally well in the absence and the presence of NGF, however, receptor degradation in the presence of NGF occurred after the receptor was post-translationally modi®ed. These data suggest that, newly synthesized trkA molecules become incorporated into the plasma membrane upon which they interact with the ligand thereby inducing receptor degradation. To determine the ligand concentration required for receptor degradation we incubated GOTO cells previously grown for 24 h in RA with increasing concentrations of NGF for an additional 24 h upon which the trkA protein was immunoprecipitated and analysed by immunoblotting with either an anti-trkA or anti PY antibody ( Figure  6c ). Almost complete trkA receptor depletion was obtained in cells grown in medium supplemented with 5 ng/ml of NGF, representing near physiological conditions. Similar data were also obtained with HTLA230 cells expressing high levels of trkA and less than 10 ng/ml was required to completely deplete the trkA receptor pool. Thus, down regulation of total trkA protein by NGF occurred by an increased rate of receptor degradation. The molecular mechanisms underlying receptor degradation are slowly being uncovered, and recently the association of the GRB2 adapter molecule was shown to be required for ligandinduced EGF receptor degradation (Wang and Moran, 1996) . We and others have previously shown that GRB2 is rapidly associated with trkA upon NGF stimulation (Torres and Bogenmann, 1996) , and it is likely that trkA down regulation occurs by a similar mechanism. It is however worth noting that transcriptional regulation of trkA gene expression and the posttranscriptional regulation of trkA protein by NGF seems to be intact in both GOTO and HTLA230 NB cells, despite their highly malignant nature.
Induction of functional trkA receptors in NB may be a useful tool for treatment, since expression of trkA in NB directly correlates with favorable outcome. Thus, we investigated the long term biological consequences of elevated trkA expression in GOTO and HTLA230 cells. GOTO cells were grown either in medium alone, or medium supplemented with RA, NGF, or RA + NGF and analysed morphologically (Figure 7) . RA induced short, neurite-like processes Figure 6 (a) Receptor biosynthesis was investigated in GOTO cells pretreated with RA for 24 h followed by growth in the absence or presence of NGF. Radiolabeled amino acids were added for 15 min at indicated time points upon which total cell lysates were prepared and immunoprecipitated with an anti-trk antibody. Immunoprecipitates were either immunoblotted with the trk antibody or analysed by autoradiography. Total trkA protein was rapidly degraded in cells grown in the presence of NGF and was nearly completely absent within 2 h. However, the amount of newly synthesized trkA protein seemed to be unaected by the presence of NGF, since the incorporation rate of radiolabeled amino acids was independent of the presence of NGF. (b) Receptor degradation was analysed in GOTO cells pretreated with RA for 24 h followed by incubation for 30 min with radiolabeled amino acids. The label was washed out and cells were subsequently grown in the absence or presence of NGF. Total cell lysates were prepared at indicated time points and analysed as above. Rapid degradation of the total trkA protein occurred in the presence of NGF, consistent with our previous data. However, autoradiographic analysis demonstrated that newly synthesized trkA protein migrates with an approximate molecular weight of 110 kDa. This protein then matures within 1 h to assume a molecular weight of 140 kDa. The mature receptor is degraded in the presence of NGF, consistent with the model of a ligand induced increase in receptor degradation. (c) NGF induced trkA receptor down regulation was analysed in HTLA230 cells previously stimulated with CNTF. Decreasing concentrations of NGF were added to cells for 24 h. Cell lysates were analysed by immunoprecipitation and immunoblotting for trk and PY. Incubation of cells with 5 ng/ml of NGF nearly completely down regulated the level of trkA protein, demonstrating that post translational regulation of the receptor occurred at physiological concentrations of NGF (Figure 7b ) not seen in untreated cells (Figure 7a) , consistent with previous observations (Tahira et al., 1991) . NGF alone (Figure 7c) showed no eect on the cell morphology, while cells grown in RA + NGF showed a¯at morphology, similar to that seen in untreated control cells. Hence, a combination of RA and NGF seem to reverse the RA-induced phenotype. A possible explanation for this observation could be that RA treatment induces apoptosis in GOTO cells which is counteracted by NGF through the elevated expression of trkA. We can not exclude that NGF acts as survival factor in RA treated GOTO cells, however, previous studies did not indicate an apoptotic response, in contrast RA was shown to induce morphological and molecular neuronal dierentiation (Tahira et al., 1991) , consistent with our data. Furthermore, we did not observe DNA fragmentation, typical of apoptotic cells, following treatment with the indicated RA concentration. Alternatively, increased expression of trkA may induce cell proliferation in the presence of NGF as previously described . To test this possibility, cells were grown in medium alone or medium supplemented with RA, NGF, or RA + NGF, and triplicate cultures were counted at indicated time intervals (Figure 8a ). Cells grown in medium alone or medium supplemented with NGF showed an equal growth rate, while treatment with RA significantly inhibited cell proliferation after 4 days, as previously observed (Matsushima and Bogenmann, 1992a; Thiele et al., 1985) . In contrast, cells grown in a combination of RA + NGF showed a transient cell , and dierent agents were added 2 days thereafter. Data represent the mean of triplicate cultures. GOTO cells grown in medium alone or medium supplemented with NGF showed similar growth kinetics, while RA treatment induced a growth arrest after 4 days consistent with previous observations (Matsushima and Bogenmann, 1992a, b) . However, cells grown in RA + NGF showed a greater than twofold increase in total cell number over RA alone, suggesting that NGF transiently induced cell proliferation in RA pretreated GOTO cells. (b) Incorporation of 3 HTdR (1 mCi/ml) was determined in duplicate cultures in order to analyse DNA synthesis in GOTO cells grown under the above culture conditions. Equal incorporation of the label occurred in cells grown in medium alone or supplemented with NGF, while RA signi®cantly suppressed DNA synthesis. However, a greater than 2.5-fold increase of 3 HTdR incorporation was observed in GOTO cells grown in the presence of RA + NGF, consistent with the hypothesis that NGF acted as mitogen in RA pretreated GOTO cells proliferation resulting in a twofold increase in total cell number over cells grown in RA alone. This increase was clearly evident 2 days after addition of NGF; however, since NGF also rapidly down regulates trkA protein, no further growth stimulation occurred. To substantiate a mitogenic response, we measured [ 3 H]-thymidine ( 3 HTdR) incorporation into cells grown under the above culture conditions at day 3, where equal cell numbers were still present (Figure 8b ). An equal rate of 3 HTdR incorporation into cells grown in medium or medium supplemented with NGF was observed, while RA signi®cantly reduced incorporation of the label. In contrast, cells treated with RA + NGF demonstrated a 2.5-fold increase in 3 HTdR incorporation when compared to cells grown in RA alone, consistent with the above-observed NGFmediated increase in total cell number. Interestingly, similar observations were made with RA treated S5Y5 NB cells expressing elevated levels of trkB receptors in the presence of BDNF (Matsumoto et al., 1995) .
The biological response of HTLA230 cells to NGF following stimulation with CNTF was analysed ( Figure  9 ). Cells grown for 3 days on an ECM in medium alone (Figure 9a ), or medium supplemented with NGF (Figure 9b ), or CNTF (Figure 9c ) alone showed an undierentiated cell morphology, demonstrating that neither the ECM, nor NGF, or CNTF had any eect. However, growth of HTLA230 cells in the presence of CNTF + NGF (Figure 9d ) generated cells which extended many long, bifurcated processes characteristic of neurites Bogenmann, 1992a, 1993) . The soma of these cells was very small, typical of post-mitotic, dierentiated NB cells, previously observed with HTLA230 cells expressing a transfected trkA gene (Matsushima and Bogenmann, 1993) . Taken together, these data demonstrate that activation of trkA gene expression in NB cells by various agents results in the presence of functional trkA receptors capable of eliciting a biological response upon NGF stimulation. This response may lead either to cell proliferation or dierentiation, depending on the tumor from which the cells were isolated.
Our data demonstrate that GOTO and HTLA230 cells dier in their biological response to agents such as RA and NGF. It has been postulated that NB can dierentiate into either neuronal or glial cells, suggesting that NB derives from bi-potent progenitor cells. Indeed, GOTO cells express vimentin, a marker previously associated with NB cells dierentiating along the glial/schwann cell lineage. Thus, GOTO tumor cells may have developed from a glial precursor in which NGF is mitogenic, while HTLA230 cells arose from progenitor cells that dierentiate into neurons when expressing trkA. This was substantiated by transfection of the trkA cDNA into GOTO cells which did not dierentiate into neuron-like cells in the presence of NGF, as is the case with HTLA230 cells (data not shown) (Matsushima and Bogenmann, 1993) . Interestingly, the N-myc gene is ampli®ed in both cell lines, yet activation of trkA gene expression occurs despite high N-myc gene expression in GOTO cells, since RA treatment does not down regulate Nmyc gene expression. In contrast, CNTF mediated trkA activation in HTLA230 cells, followed by treatment with NGF, leads to reduced N-myc gene expression, also observed with HTLA230 cells expressing the transfected human trkA cDNA (Matsushima and Bogenmann, 1993) . These ®ndings indicate that lack of trkA gene expression in advanced NB tumors is not due to N-myc mediated repression of the trkA gene, but may be the consequence of the undifferentiated state of the neuroblastic progenitor cell from which the tumor derived. Thus, our data suggest, that there are intrinsic biological dierences between these two NB cell lines, despite sharing many common properties of an advanced NB tumor. Our observation that NGF may elicit a proliferative response in some NB is important, since a neurotrophin/cytokine-based treatment modality could represent an alternative strategy to currently used protocols. Furthermore, we suggest, that the analysis of a biological response of NB to neurotrophins and/or cytokines can be used to characterize NB based on its functional biological properties.
Materials and methods

Cell culture
The GOTO human NB cell line (Sekiguchi et al., 1979) was obtained from the Japanese Cancer Research Resources Bank and grown in Dulbecco's modi®ed Eagle's medium (Irvine Scienti®c, Irvine, CA), supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Irvine Scienti®c), penicillin-streptomycin and glutamine (all from Gibco Laboratories, Grand Island, NY). The characterization of HTLA230 cells has been described elsewhere (Matsushima and Bogenmann, 1992a,b; 1993) . All-trans- 
